See more : YIT Oyj (YIT.HE) Income Statement Analysis – Financial Results
Complete financial analysis of Kopran Limited (KOPRAN.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kopran Limited, a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
- ZheJiang KangLongDa Special Protection Technology Co., Ltd (603665.SS) Income Statement Analysis – Financial Results
- Delcath Systems, Inc. (DCTH) Income Statement Analysis – Financial Results
- Nittetsu Mining Co., Ltd. (1515.T) Income Statement Analysis – Financial Results
- Tianneng Power International Limited (0819.HK) Income Statement Analysis – Financial Results
- Public Joint Stock Company United Aircraft Corporation (UNAC.ME) Income Statement Analysis – Financial Results
Kopran Limited (KOPRAN.BO)
About Kopran Limited
Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as topical preparations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. In addition, the company provides drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, antipeptic ulcer and gut, and others. Kopran Limited was incorporated in 1958 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.10B | 5.48B | 4.74B | 4.81B | 3.50B | 3.49B | 3.05B | 3.01B | 2.96B | 3.26B | 3.03B | 2.50B | 1.99B | 1.95B | 1.64B | 1.19B | 0.00 |
| Cost of Revenue | 4.67B | 3.74B | 2.84B | 3.14B | 2.20B | 2.20B | 2.01B | 1.93B | 1.86B | 2.12B | 1.88B | 1.54B | 1.27B | -56.86M | 1.02B | 772.76M | 0.00 |
| Gross Profit | 1.43B | 1.74B | 1.90B | 1.67B | 1.30B | 1.28B | 1.04B | 1.08B | 1.11B | 1.14B | 1.15B | 960.18M | 719.93M | 2.00B | 627.99M | 413.56M | 0.00 |
| Gross Profit Ratio | 23.44% | 31.77% | 40.10% | 34.72% | 37.15% | 36.83% | 34.13% | 35.97% | 37.32% | 34.95% | 38.01% | 38.37% | 36.19% | 102.92% | 38.21% | 34.86% | 0.00% |
| Research & Development | 0.00 | 6.43M | 6.65M | 5.94M | 291.00K | 187.00K | 48.00K | 40.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 104.56M | 91.48M | 85.48M | 85.58M | 74.05M | 53.42M | 51.54M | 51.90M | 0.00 | 0.00 | 39.55M | 29.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 94.04M | 93.07M | 85.44M | 182.17M | 138.91M | 143.29M | 151.27M | 135.16M | 0.00 | 0.00 | 135.37M | 106.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 859.55M | 184.54M | 170.92M | 267.75M | 212.97M | 196.71M | 202.80M | 187.06M | 322.05M | 313.92M | 455.72M | 384.21M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 6.24M | 11.78M | 9.01M | 63.00K | 25.70M | 1.26M | 2.91M | -8.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 859.55M | 1.29B | 1.13B | 938.77M | 914.38M | 880.61M | 801.78M | 781.79M | 870.64M | 914.35M | 853.36M | 744.95M | 620.00M | 587.29M | 558.50M | 466.09M | 0.00 |
| Cost & Expenses | 5.45B | 5.03B | 3.98B | 4.08B | 3.12B | 3.08B | 2.81B | 2.71B | 2.73B | 3.03B | 2.73B | 2.29B | 1.89B | -56.86M | 1.57B | 1.24B | 0.00 |
| Interest Income | 3.01M | 17.01M | 13.25M | 2.93M | 4.59M | 3.60M | 7.55M | 4.52M | 4.62M | 1.97M | 7.19M | 17.96M | 23.17M | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 85.93M | 45.05M | 36.27M | 45.15M | 69.56M | 65.55M | 53.35M | 87.89M | 69.69M | 72.06M | 78.58M | 118.80M | 96.65M | 74.86M | 61.81M | 85.62M | 0.00 |
| Depreciation & Amortization | 128.87M | 127.28M | 111.16M | 102.07M | 95.77M | 87.39M | 85.13M | 83.31M | 81.18M | 96.43M | 129.21M | 124.63M | 118.04M | 116.22M | 115.46M | 113.69M | 0.00 |
| EBITDA | 890.40M | 548.77M | 980.11M | 997.82M | 467.72M | 493.92M | 399.93M | 467.93M | 313.97M | -165.12M | 445.59M | 354.61M | 268.08M | 219.17M | 184.95M | 61.16M | 0.00 |
| EBITDA Ratio | 14.59% | 9.72% | 20.32% | 20.58% | 13.18% | 14.26% | 12.69% | 14.73% | 9.11% | 9.89% | 12.30% | 13.58% | 10.96% | 2.92% | 11.25% | 5.16% | 0.00% |
| Operating Income | 615.26M | 445.21M | 764.53M | 640.59M | 294.68M | 292.23M | 220.59M | 250.39M | 107.19M | -391.24M | 171.78M | 111.19M | 53.40M | -59.37M | 69.49M | -52.53M | 0.00 |
| Operating Income Ratio | 10.08% | 8.12% | 16.12% | 13.30% | 8.41% | 8.38% | 7.24% | 8.31% | 3.62% | -12.01% | 5.67% | 4.44% | 2.68% | -3.05% | 4.23% | -4.43% | 0.00% |
| Total Other Income/Expenses | 60.18M | -84.55M | 50.21M | 100.23M | -104.65M | -87.09M | 8.27M | -2.79M | -126.18M | -613.74M | -125.11M | -100.73M | 0.00 | -45.99M | -61.81M | -85.61M | 0.00 |
| Income Before Tax | 675.45M | 360.66M | 817.81M | 833.36M | 282.84M | 316.63M | 228.85M | 247.60M | 107.19M | -391.24M | 171.78M | 111.19M | 53.40M | 42.64M | 7.68M | -138.14M | 0.00 |
| Income Before Tax Ratio | 11.07% | 6.58% | 17.24% | 17.31% | 8.07% | 9.08% | 7.51% | 8.22% | 3.62% | -12.01% | 5.67% | 4.44% | 2.68% | 2.19% | 0.47% | -11.64% | 0.00% |
| Income Tax Expense | 165.89M | 88.33M | 207.50M | 217.30M | 72.63M | 76.40M | 23.99M | 48.48M | -49.37M | 616.86M | 71.53M | 103.96M | 46.53M | -2.71M | 74.39M | -249.00K | 0.00 |
| Net Income | 509.56M | 272.33M | 610.31M | 616.06M | 210.20M | 240.23M | 204.86M | 199.12M | 107.19M | -391.24M | 171.78M | 111.19M | 53.40M | 48.60M | 4.75M | 137.89M | 0.00 |
| Net Income Ratio | 8.35% | 4.97% | 12.87% | 12.80% | 6.00% | 6.89% | 6.72% | 6.61% | 3.62% | -12.01% | 5.67% | 4.44% | 2.68% | 2.50% | 0.29% | 11.62% | 0.00% |
| EPS | 10.57 | 5.65 | 13.77 | 14.24 | 4.86 | 5.55 | 4.74 | 4.60 | 2.59 | -9.84 | 4.40 | 2.85 | 1.37 | 1.10 | -0.05 | 4.00 | 0.00 |
| EPS Diluted | 10.57 | 5.65 | 13.77 | 14.24 | 4.86 | 5.55 | 4.74 | 4.60 | 2.59 | -9.84 | 4.40 | 2.85 | 1.37 | 1.10 | -0.05 | 4.00 | 0.00 |
| Weighted Avg Shares Out | 48.21M | 48.21M | 44.31M | 43.25M | 43.25M | 43.25M | 43.25M | 43.25M | 41.40M | 39.76M | 39.05M | 39.05M | 39.05M | 39.05M | 36.22M | 35.25M | 0.00 |
| Weighted Avg Shares Out (Dil) | 48.21M | 48.21M | 44.31M | 43.25M | 43.25M | 43.25M | 43.25M | 43.25M | 41.40M | 39.76M | 39.05M | 39.05M | 39.05M | 39.05M | 36.22M | 35.25M | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports